Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/10/23
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/10/23
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingGlobeNewsWire • 05/25/23
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/23
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business HighlightsGlobeNewsWire • 05/09/23
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/03/23
Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 03/16/23
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business UpdatesGlobeNewsWire • 02/23/23
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023GlobeNewsWire • 02/16/23
Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma ConferenceGlobeNewsWire • 02/09/23
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023GlobeNewsWire • 01/09/23
Shattuck Labs, Inc. (STTK) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 12/01/22
Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business HighlightsGlobeNewsWire • 11/08/22
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 11/07/22
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022GlobeNewsWire • 11/01/22
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12GlobeNewsWire • 10/05/22
Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/11/22
Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business HighlightsGlobeNewsWire • 05/12/22